Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Transplantation|January 24, 2008
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotypeIain A M MacPhee, David W Holt
Inflammatory Bowel Diseases|April 29, 1998
Quality-of-life factors in adolescent inflammatory bowel diseaseM MacPhee, E J Hoffenberg, A Feranchak
Plastic and Reconstructive Surgery|November 1, 1995
Delivery of demineralized bone powder by fibrin sealantC Lasa, J Hollinger, W Drohan, et al.
Journal of Nursing Management|June 30, 2016
Disentangling the relationships between staff nurses' workplace empowerment and job satisfactionV S Dahinten, S E Lee, M MacPhee
Expert Opinion on Pharmacotherapy|December 1, 2005
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Iain A M MacPhee, Salim Fredericks, David W Holt
Therapeutic Drug Monitoring|May 14, 2013
CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipientsN Spierings, D W Holt, Iain A M MacPhee
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 25, 2003
The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administrationSalim Fredericks, David W Holt, Iain A M MacPhee
Infection|February 23, 1999
Subverting bacterial resistance using high dose, low solubility antibiotics in fibrinC J Woolverton, K Huebert, B Burkhart, et al.
Expert Opinion on Pharmacotherapy|August 24, 2007
Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantationFu Liang Ng, David W Holt, Iain A M MacPhee
Critical Care Research and Practice|March 12, 2013
Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injuryChristopher J Kirwan, Barbara J Philips, Iain A M Macphee
Pageof 7